Nepal Rastra Bank has fixed the foreign exchange rates for today. According to the published rates, the buying rate for one ...

Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. Wegovy sales of DKK 17.36 billion in Q1, fell short of Wall Street’s expectation of DKK 18.51 billion, as ...

Gubra releases its results for the first quarter of 2025. The key development in the quarter was the out-licensing agreement to AbbVie for our anti-obesity asset GUBamy (Amylin). A landmark deal ...

Stocks on Sweden's OMX Stockholm 30 Index held steady at 2,448.97, while Norway's Oslo Exchange Benchmark Index_GI fell 0.6%. Shares in Iceland increased, with the OMX Iceland All-Share PI Equity ...

Nepal Rastra Bank has published the official foreign exchange rates for today. According to the rates, the buying rate for one US dollar stands at Rs 134.80, while the selling rate is Rs ...

Novo Nordisk is hedging and building its way around a global tariff war that may threaten the Wegovy maker’s plans to expand ...

Truecaller AB Series B posted the largest decline among large stocks during the session, plunging 12.2%, followed by Sagax AB Series A shares, which plunged 11.5%. Shares of Zealand Pharma A/S ...

New higher loan to value (LTV) expat mortgages are now expanding. Just released, there are now up to 90% LTV mortgages ...

The FDA in February formally declared the end of the semaglutide shortage, which Novo Nordisk expects will help improve the ...

Novo Nordisk Q1 sales missed estimates despite strong growth in Wegovy and Ozempic, prompting a cut to its 2025 guidance amid ...

European markets closed lower on Wednesday, with traders monitoring corporate earnings and awaiting the Federal Reserve’s ...

Novo Nordisk's Q1 2025 results show a 19% sales increase, 20% operating income growth, and 14% net profit rise. Read why NVO ...